Cardima/FDA Meeting Planned To Clarify Revelation Tx Reporting Issues
This article was originally published in The Gray Sheet
Executive Summary
Cardima is planning a September meeting with FDA to discuss perceived protocol compliance problems with the clinical trial of its Revelation Tx ablation catheter